Improved quality control of [177Lu]Lu-PSMA I&T

被引：0
|
作者：
Martin Kraihammer
Piotr Garnuszek
Andreas Bauman
Michael Maurin
Manuel Alejandre Lafont
Roland Haubner
Elisabeth von Guggenberg
Michael Gabriel
Clemens Decristoforo
机构：
[1] Medical University Innsbruck,Department of Nuclear Medicine
[2] Kepler University Hospital,Department of Nuclear Medicine and Endocrinology
[3] National Centre for Nuclear Research,Radioisotope Centre POLATOM
[4] University Hospital Basel,Division of Radiopharmaceutical Chemistry
来源：
EJNMMI Radiopharmacy and Chemistry | / 8卷
关键词：
PSMA; [; Lu]Lu-PSMA I&T; Zadavotide guraxetan; Radionuclide therapy; Quality control; HPLC; TLC; Validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [2] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [3] Quality control of [177Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery
    Aalbersberg, Else A.
    Cao, Tammie T.
    Geluk-Jonker, Martine M.
    Hendrikx, Jeroen J. M. A.
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2022, 7 (01)
  • [4] Quality control of [177Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery
    Else A. Aalbersberg
    Tammie T. Cao
    Martine M. Geluk-Jonker
    Jeroen J. M. A. Hendrikx
    EJNMMI Radiopharmacy and Chemistry, 7
  • [5] Prognostic Performance of RECIP 1.0 Based on [18F]PSMA-1007 PET in Prostate Cancer Patients Treated with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Huttmann, Thomas
    Seitz, Anna Katharina
    Kubler, Hubert
    Serfling, Sebastian E.
    Higuchi, Takahiro
    Telburg, Wiebke Schlo euro
    Michalski, Kerstin
    Gafita, Andrei
    Rowe, Steven P.
    Pomper, Martin G.
    Buck, Andreas K.
    Werner, Rudolf A.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 560 - 565
  • [6] SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
    Philipp E. Hartrampf
    Thomas Hüttmann
    Anna Katharina Seitz
    Hubert Kübler
    Sebastian E. Serfling
    Wiebke Schlötelburg
    Kerstin Michalski
    Steven P. Rowe
    Martin G. Pomper
    Andreas K. Buck
    Uta Eberlein
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3465 - 3474
  • [7] SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Huettmann, Thomas
    Seitz, Anna Katharina
    Kuebler, Hubert
    Serfling, Sebastian E.
    Schloetelburg, Wiebke
    Michalski, Kerstin
    Rowe, Steven P.
    Pomper, Martin G.
    Buck, Andreas K.
    Eberlein, Uta
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3465 - 3474
  • [8] Radioactivity levels in the saliva of patients undergoing targeted radioligand therapy with [177Lu]Lu-PSMA-I&T and [177Lu]Lu-DOTA-TOC
    Christian Schedeit
    Nasir Gözlügöl
    Radi Saiyed Alsheikh
    Mohamed Shelan
    Robert Seifert
    Federico Caobelli
    Urs Borner
    Tateyuki Iizuka
    Benoît Schaller
    Axel Rominger
    Paul Cumming
    Ali Afshar-Oromieh
    Konstantinos G. Zeimpekis
    Clinical Oral Investigations, 29 (5)
  • [9] Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry
    Uijen, Maike J. M.
    Prive, Bastiaan M.
    van Herpen, Carla M. L.
    Westdorp, Harm
    van Gemert, Willemijn A.
    de Bakker, Maarten
    Gotthardt, Martin
    Konijnenberg, Mark W.
    Peters, Steffie M. B.
    Nagarajah, James
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (04) : 270 - 275
  • [10] Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
    Philipp E. Hartrampf
    Anna Katharina Seitz
    Franz-Xaver Weinzierl
    Sebastian E. Serfling
    Andreas Schirbel
    Steven P. Rowe
    Hubert Kübler
    Andreas K. Buck
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4262 - 4270
12345